Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.27 Billion CNY | 3.52% |
| 2022 | 9.92 Billion CNY | 23.17% |
| 2021 | 8.06 Billion CNY | 15.97% |
| 2020 | 6.95 Billion CNY | 21.92% |
| 2019 | 5.7 Billion CNY | 0.24% |
| 2018 | 5.68 Billion CNY | 21.94% |
| 2017 | 4.66 Billion CNY | 36.23% |
| 2016 | 3.42 Billion CNY | 4.77% |
| 2015 | 3.26 Billion CNY | 1.47% |
| 2014 | 3.22 Billion CNY | 8.74% |
| 2013 | 2.96 Billion CNY | 20.7% |
| 2012 | 2.45 Billion CNY | 54.19% |
| 2011 | 1.59 Billion CNY | 55.58% |
| 2010 | 1.02 Billion CNY | 13.79% |
| 2009 | 898.91 Million CNY | -17.48% |
| 2008 | 1.08 Billion CNY | 14.09% |
| 2007 | 954.79 Million CNY | -11.58% |
| 2006 | 1.07 Billion CNY | 16.72% |
| 2005 | 925.19 Million CNY | -10.17% |
| 2004 | 1.02 Billion CNY | 7.88% |
| 2003 | 954.69 Million CNY | 31.31% |
| 2002 | 727.05 Million CNY | 13.71% |
| 2001 | 639.37 Million CNY | 10.0% |
| 2000 | 581.23 Million CNY | -0.46% |
| 1999 | 583.95 Million CNY | 18.09% |
| 1998 | 494.5 Million CNY | 4.45% |
| 1997 | 473.43 Million CNY | -13.46% |
| 1996 | 547.09 Million CNY | 22.26% |
| 1995 | 447.49 Million CNY | 81.43% |
| 1994 | 246.64 Million CNY | -1.58% |
| 1993 | 250.59 Million CNY | -21.37% |
| 1992 | 318.7 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 9.75 Billion CNY | -5.14% |
| 2024 Q3 | 9.97 Billion CNY | -9.07% |
| 2024 Q2 | 10.96 Billion CNY | 12.5% |
| 2023 Q2 | 11.47 Billion CNY | 12.46% |
| 2023 FY | 10.27 Billion CNY | 3.52% |
| 2023 Q4 | 10.27 Billion CNY | -0.52% |
| 2023 Q1 | 10.2 Billion CNY | 2.78% |
| 2023 Q3 | 10.33 Billion CNY | -9.97% |
| 2022 Q2 | 8.95 Billion CNY | 1.72% |
| 2022 Q3 | 9.05 Billion CNY | 1.2% |
| 2022 Q4 | 9.92 Billion CNY | 9.61% |
| 2022 FY | 9.92 Billion CNY | 23.17% |
| 2022 Q1 | 8.79 Billion CNY | 9.16% |
| 2021 Q4 | 8.06 Billion CNY | 4.67% |
| 2021 Q3 | 7.7 Billion CNY | 1.26% |
| 2021 FY | 8.06 Billion CNY | 15.97% |
| 2021 Q2 | 7.6 Billion CNY | 5.22% |
| 2021 Q1 | 7.22 Billion CNY | 3.99% |
| 2020 Q2 | 4.71 Billion CNY | -1.62% |
| 2020 Q1 | 4.79 Billion CNY | -15.9% |
| 2020 FY | 6.95 Billion CNY | 21.92% |
| 2020 Q3 | 6.2 Billion CNY | 31.5% |
| 2020 Q4 | 6.95 Billion CNY | 12.06% |
| 2019 FY | 5.7 Billion CNY | 0.24% |
| 2019 Q4 | 5.7 Billion CNY | 29.83% |
| 2019 Q3 | 4.39 Billion CNY | -17.2% |
| 2019 Q2 | 5.3 Billion CNY | 21.52% |
| 2019 Q1 | 4.36 Billion CNY | -23.26% |
| 2018 Q3 | 4.04 Billion CNY | -12.0% |
| 2018 Q4 | 5.68 Billion CNY | 40.62% |
| 2018 FY | 5.68 Billion CNY | 21.94% |
| 2018 Q1 | 4.67 Billion CNY | 0.25% |
| 2018 Q2 | 4.59 Billion CNY | -1.7% |
| 2017 Q2 | 8.04 Billion CNY | 104.34% |
| 2017 Q4 | 4.66 Billion CNY | 2.21% |
| 2017 Q3 | 4.56 Billion CNY | -43.31% |
| 2017 Q1 | 3.93 Billion CNY | 15.06% |
| 2017 FY | 4.66 Billion CNY | 36.23% |
| 2016 FY | 3.42 Billion CNY | 4.77% |
| 2016 Q4 | 3.42 Billion CNY | -4.94% |
| 2016 Q3 | 3.6 Billion CNY | 3.57% |
| 2016 Q2 | 3.47 Billion CNY | 8.34% |
| 2016 Q1 | 3.2 Billion CNY | -1.78% |
| 2015 Q3 | 3.28 Billion CNY | -0.54% |
| 2015 FY | 3.26 Billion CNY | 1.47% |
| 2015 Q1 | 3.17 Billion CNY | -1.39% |
| 2015 Q2 | 3.3 Billion CNY | 4.11% |
| 2015 Q4 | 3.26 Billion CNY | -0.62% |
| 2014 Q3 | 3.55 Billion CNY | 8.52% |
| 2014 Q1 | 3.32 Billion CNY | 12.13% |
| 2014 Q2 | 3.27 Billion CNY | -1.3% |
| 2014 FY | 3.22 Billion CNY | 8.74% |
| 2014 Q4 | 3.22 Billion CNY | -9.46% |
| 2013 Q2 | 3.29 Billion CNY | 25.28% |
| 2013 FY | 2.96 Billion CNY | 20.7% |
| 2013 Q4 | 2.96 Billion CNY | -2.2% |
| 2013 Q1 | 2.63 Billion CNY | 7.19% |
| 2013 Q3 | 3.02 Billion CNY | -8.1% |
| 2012 Q4 | 2.45 Billion CNY | 2.93% |
| 2012 FY | 2.45 Billion CNY | 54.19% |
| 2012 Q3 | 2.38 Billion CNY | 52.11% |
| 2012 Q1 | 1.43 Billion CNY | -10.08% |
| 2012 Q2 | 1.56 Billion CNY | 9.53% |
| 2011 FY | 1.59 Billion CNY | 55.58% |
| 2011 Q4 | 1.59 Billion CNY | 12.46% |
| 2011 Q3 | 1.41 Billion CNY | 5.32% |
| 2011 Q2 | 1.34 Billion CNY | 24.94% |
| 2011 Q1 | 1.07 Billion CNY | 5.12% |
| 2010 Q1 | 828.15 Million CNY | -7.87% |
| 2010 Q4 | 1.02 Billion CNY | -0.82% |
| 2010 FY | 1.02 Billion CNY | 13.79% |
| 2010 Q3 | 1.03 Billion CNY | 11.02% |
| 2010 Q2 | 928.93 Million CNY | 12.17% |
| 2009 Q4 | 898.91 Million CNY | 0.98% |
| 2009 Q1 | 886.96 Million CNY | -18.57% |
| 2009 Q2 | 846.36 Million CNY | -4.58% |
| 2009 Q3 | 890.2 Million CNY | 5.18% |
| 2009 FY | 898.91 Million CNY | -17.48% |
| 2008 Q1 | 1 Billion CNY | 5.01% |
| 2008 Q2 | 1.17 Billion CNY | 17.17% |
| 2008 FY | 1.08 Billion CNY | 14.09% |
| 2008 Q3 | 1.13 Billion CNY | -3.21% |
| 2008 Q4 | 1.08 Billion CNY | -4.2% |
| 2007 Q2 | 1.04 Billion CNY | -4.93% |
| 2007 Q4 | 954.79 Million CNY | -7.45% |
| 2007 FY | 954.79 Million CNY | -11.58% |
| 2007 Q1 | 1.09 Billion CNY | 1.8% |
| 2007 Q3 | 1.03 Billion CNY | -1.28% |
| 2006 Q3 | 1.14 Billion CNY | -5.86% |
| 2006 FY | 1.07 Billion CNY | 16.72% |
| 2006 Q4 | 1.07 Billion CNY | -5.55% |
| 2006 Q2 | 1.21 Billion CNY | 19.83% |
| 2006 Q1 | 1.01 Billion CNY | 9.54% |
| 2005 Q4 | 925.19 Million CNY | 0.3% |
| 2005 Q3 | 922.39 Million CNY | 2.54% |
| 2005 Q2 | 899.56 Million CNY | -1.46% |
| 2005 Q1 | 912.9 Million CNY | -11.37% |
| 2005 FY | 925.19 Million CNY | -10.17% |
| 2004 Q4 | 1.02 Billion CNY | 24.25% |
| 2004 Q3 | 828.95 Million CNY | -17.24% |
| 2004 Q2 | 1 Billion CNY | 49.6% |
| 2004 Q1 | 669.55 Million CNY | -29.87% |
| 2004 FY | 1.02 Billion CNY | 7.88% |
| 2003 Q2 | 632.28 Million CNY | -12.75% |
| 2003 Q1 | 724.7 Million CNY | -0.32% |
| 2003 FY | 954.69 Million CNY | 31.31% |
| 2003 Q4 | 954.69 Million CNY | 51.28% |
| 2003 Q3 | 631.08 Million CNY | -0.19% |
| 2002 Q3 | 798.55 Million CNY | -0.35% |
| 2002 Q1 | 728.24 Million CNY | 13.9% |
| 2002 FY | 727.05 Million CNY | 13.71% |
| 2002 Q2 | 801.38 Million CNY | 10.04% |
| 2002 Q4 | 727.05 Million CNY | -8.95% |
| 2001 Q4 | 639.37 Million CNY | 0.0% |
| 2001 Q2 | 628.9 Million CNY | 0.0% |
| 2001 FY | 639.37 Million CNY | 10.0% |
| 2000 Q4 | 581.23 Million CNY | 0.0% |
| 2000 Q2 | 646.23 Million CNY | 0.0% |
| 2000 FY | 581.23 Million CNY | -0.46% |
| 1999 FY | 583.95 Million CNY | 18.09% |
| 1999 Q2 | 518.28 Million CNY | 0.0% |
| 1999 Q4 | 583.95 Million CNY | 0.0% |
| 1998 Q4 | 494.5 Million CNY | 0.0% |
| 1998 Q2 | 443.92 Million CNY | 0.0% |
| 1998 FY | 494.5 Million CNY | 4.45% |
| 1997 Q4 | 473.43 Million CNY | 0.0% |
| 1997 FY | 473.43 Million CNY | -13.46% |
| 1997 Q2 | 455.25 Million CNY | 0.0% |
| 1996 Q2 | 399.83 Million CNY | 0.0% |
| 1996 Q4 | 547.09 Million CNY | 0.0% |
| 1996 FY | 547.09 Million CNY | 22.26% |
| 1995 Q4 | 447.49 Million CNY | 0.0% |
| 1995 FY | 447.49 Million CNY | 81.43% |
| 1995 Q2 | 389.9 Million CNY | 0.0% |
| 1994 Q4 | 246.64 Million CNY | 0.0% |
| 1994 Q2 | 235.88 Million CNY | 0.0% |
| 1994 FY | 246.64 Million CNY | -1.58% |
| 1993 FY | 250.59 Million CNY | -21.37% |
| 1992 FY | 318.7 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -7123.77% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | -41.869% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -5931.515% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -1348.329% |
| Qianhai Health Holdings Limited | 94 Million HKD | -10833.826% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -1005.093% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -1037.236% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -1444.679% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -1390.337% |
| SSY Group Limited | 4.49 Billion HKD | -128.711% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -2702.465% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | -842.52% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 93.899% |